Cargando…
Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer
BACKGROUND: Recruitment for randomised controlled trials in palliative care can be challenging; disease progression and terminal illness underpin high rates of attrition. Research into participant decision-making in medicinal cannabis randomised controlled trials (RCTs) is very limited. Nesting qual...
Autores principales: | Olson, Rebecca E., Smith, Alexandra, Huggett, Georgie, Good, Phillip, Dudley, Morgan, Hardy, Janet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444122/ https://www.ncbi.nlm.nih.gov/pubmed/36064621 http://dx.doi.org/10.1186/s13063-022-06691-1 |
Ejemplares similares
-
Exploring potential anti-inflammatory effects of medicinal cannabis
por: Gurgenci, Taylan, et al.
Publicado: (2023) -
‘What price do you put on your health?’: Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer
por: Olson, Rebecca E., et al.
Publicado: (2022) -
An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care
por: Good, Phillip D., et al.
Publicado: (2020) -
The Association between Cannabis Product Characteristics and Symptom Relief
por: Stith, Sarah S., et al.
Publicado: (2019) -
Patient-Reported Symptom Relief Following Medical Cannabis Consumption
por: Stith, Sarah S., et al.
Publicado: (2018)